Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk
|
|
- Isabel Willis
- 5 years ago
- Views:
Transcription
1 Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk H Kakinuma 1, N Tsuchiya 1, T Habuchi 1 *, C Ohyama 1, S Matsuura 1, L Wang 1, A Nakamura 2 & T Kato 1 1 Department of Urology, Akita University School of Medicine, Akita, Japan; and 2 Department of Medical Information Science, Akita University School of Medicine, Akita, Japan (2004) 7, & 2004 Nature Publishing Group All rights reserved /04 $ Polymorphism of the steroid hormone-related genes might affect life-long androgen exposure, thus altering a risk of prostate cancer incidence. To evaluate the effect of the polymorphisms of CYP17 and SRD5A2 on serum steroid hormone levels, the 164 male Japanese cohort were tested for serum hormone levels and the genotype of the polymorphisms of CYP17 (T C base substitution in the promoter region) and SRD5A2 (V89L). The linear trends across the CYP17 genotypes in serum-free testosterone and androstenedione levels were found, suggesting the importance of the polymorphism of CYP17 in determining the circulating androgen levels. (2004) 7, doi: /sj.pcan Published online 12 October 2004 Keywords: CYP17 gene; SRD5A2 gene; polymorphism; steroid hormones Introduction The incidence and mortality rates of prostate cancer vary significantly among countries, with Japan having the lowest mortality rate in the world, reported as 4 per between 1992 and ,2 Genetic and environment backgrounds may be major factors accounting for its worldwide and ethnic variation. According to Ross et al, 3,4 both African and European American males had 41 51% higher preandrogen levels (androsterone glucuronide), compared with Japanese males. Furthermore, de Jong et al 5 also reported that 71% higher circulating levels of testosterone were seen in Caucasian males compared with those in Japanese males. The extensive metaanalysis of previously published studies on hormonal predictors revealed that males whose total testosterone levels were in the highest quartile were 2.34-fold more likely to develop prostate cancer. 6 Although the degree to which androgen and androgen metabolites contribute to prostate cancer risk remains a contentious issue, these findings support the hypothesis that the higher incidence of prostate cancer in a population might be substantially *Correspondence: T Habuchi, Department of Urology, Akita University School of Medicine, Hondo, Akita , Japan. thabuchi@doc.med.akita-u.ac.jp Received 20 March 2004; revised 3 June 2004; accepted 6 July 2004; published online 12 October 2004 influenced by long-lasting impacts of higher circulating androgens. Several studies have addressed the hypothesis that the high/low activity alleles in the CYP17 and SRD5A2 polymorphisms could influence the incidence of prostate cancer and partially explain the observed ethnic/racial differences CYP17, located on chromosome 10q24, encodes cytochrome p450c17 that plays an important role at two key steps in testosterone biosynthesis. CYP17 harbors a single base pair mutation (T C) in the untranscribed 5 region of exon one. Conventionally, the T and C alleles are designated as the A1 allele and A2 allele, respectively. Although the results from casecontrol studies evaluating the association between the CYP17 genotype and prostate cancer risk have been contradictory, our previous study showed that the risk of prostate cancer was increased up to two-fold in males with A1 allele in a Japanese population On the other hand, SRD5A2 encodes for human type II 5a-reductase, which converts testosterone to the more potent, dihydrotestosterone (DHT), located on chromosome 2p23. Makridakis et al 15 reported that the presence of a valine (V) allele instead of a leucine (L) allele at codon 89 reduced significantly the conversion rate of testosterone to DHT, and the higher level of 5a-androstane-3a, 17bdiol glucuronide (A-diol-g) in V allele homozygous males compared with L allele homozygous and heterozygous males. In support of their observation, Nam et al 13
2 334 and Li et al 16 suggested that V allele homozygote males had a significantly decreased risk of prostate cancer. The biological importance and mechanisms of those polymorphisms have not been elucidated completely, and it has been of much interest to analyze the association between serum steroid hormone levels and these polymorphisms in view of the possible relation between the serum steroid hormone levels and a prostate cancer risk. Furthermore, those polymorphisms could be utilized as a marker of an individual s life-long hormone exposure and cancer risk susceptibility, if they really reflected serum hormone levels. In this study, five major circulating hormones, namely, dehydroepiandrosterone sulfate (DHEA S), andreostenedione, free testosterone (fte), testosterone (Te), and estradiol (E2) in 164 healthy Japanese males were measured to assess the biological relevance of those polymorphisms. Materials and methods Subjects This study group was drawn from 170 consecutive healthy males (60 80 y old) who visited a community health center for an annual health check between January and May in The 164 samples from males with normal serum PSA levels (o4.0 ng/ml, Tandem-R assay) were used for this study. In total, 12 ml of whole blood for a hormone assay and DNA analysis was donated after receiving written informal consent. The vein puncture was performed between 8:00 a.m. and 10:00 a.m. to minimize the effect of daily fluctuation. Those blood samples were immediately stored at 701C until the hormone assay. DNA extraction and hormone assays Genomic DNA was extracted using a QIAamp Blood Kit (QIAGEN, Valencia, CA, USA). DHEA S, androstenedione, fte, Te, and E2 were measured by a radioimmunoassay kit provided by the Diagnostic Products Corporation (LA, USA) in collaboration with SRL Inc. Co. (Tokyo, Japan). Samples were randomly assorted into batches. Genotype analyses SRD5A2 genotyping was performed by the PCR-RELP method as described previously. 16 The PCR primer set was designed to amplify the part of SRD5A2 that includes the polymorphic site (forward: 5 0 -CCACCTGG GACGGTACTTCT, reverse: 5 0 -CTCCACGCTGCGCTCC TGGA). PCR was carried out in a 25 ml aliquot containing 20 ng of genomic DNA template, 50 pmol of each primer, 125 mm deoxynucleotidetriphosphates, 1 U of Ampli-Taq Gold DNA polymerase (PE Applied Biosystems, Foster City, CA, USA), and 2.5 ml of 10 reaction buffer supplied by the manufacturer. PCR amplification conditions were 10 min initial denaturation at 951C followed by 35 cycles of 30 s at 941C, 30 s at 601C, and 90 s at 721C, 7 min final extension at 721C. Products were digested with 10 U of RsaI (NEB, Beverly, MA, USA) and separated by electrophoresis on Gene Gel Excel 12.5/24 (Amersham Biosciences, Inc., Piscataway, NJ, USA). DNA bands were detected by silver staining. The valine allele, which was sensitive to RsaI, resulted in two bands (35 and 89 bp), while the leucine allele was seen as a single band (124 bp). The genotypes were designated as V for the valine allele and L for the leucine allele. CYP17 genotyping was performed by the PCR-RELP method as described previously. 11 In brief, a single base pair mutation (T C) in the A2 allele creates the MspAI recognition site. The C allele was designated as A2 when the PCR product was digested by MspAI, while it was designated as A1 when the product was undigested. Statistical methods All data were entered into an access database and analyzed using Excel 2000 and SPSS (version 10.0J, SPSS) software (SPSS Institute, Inc., Chicago, IL, USA). The w 2 test was used to compare the allele and genotype frequency. Hardy Weinberg equilibrium analyses were performed to compare observed and expected genotype frequencies using a w 2 test (d.f. ¼ 1). Linear regression models were used to evaluate associations between three genotypes and circulating steroid hormone levels. 10 The least-square geometric mean hormone levels were estimated, and the differences in hormone levels between genotypes were evaluated with the A1/A1 group or the V/V group as a reference category. We also evaluated associations between the combination of the CYP17 and SRD5A2 genotypes and plasma hormone levels with the A1/A1 group and V/V group as a reference category. The interaction of the CYP17 SRD5A2 genotype was assessed including the gene gene interaction term in the linear regression models. All statistical results in this study were not age adjusted since the range and standard deviation (s.d.) of the study subjects were so narrow for age adjustment. No data concerning diet, body mass index, or life style were available. The results were considered to be significant when Po0.05. Results The age and serum PSA levels of 164 samples were y (mean7s.d.) and ng/ml, respectively. The frequencies of variant alleles of CYP17 and SRD5A2 are shown in Tables 1 and 2, respectively, and are in Hardy Weinberg equilibrium, with the expected frequencies for the CYP17 genotypes being A1/A1 ¼ 50, A1/A2 ¼ 81, and A2/A2 ¼ 32 (P ¼ 0.268); and for SRD5A2 genotypes, V/V ¼ 52, V/L ¼ 80, and L/L ¼ 31 (P ¼ 0.981) (Tables 1 and 2). The prevalence of the CYP17 A2 allele and SRD5A2 L allele were 44.5 and 43.3%, respectively. DHEA S, androstenedione, fte, Te, and E2 were measured by radioimmunoassay. Intra-assay coefficients of variation were 4.9% at ng/ml for DHEA S, 8.5% at 1.22 ng/ml for andreostenedione, 7.7% at pg/ml for fte, 4.1% at 5.49 pg/ml for Te, and 2.5% at pg/ml for E2. The values of each hormone
3 Table 1 Mean hormone levels (95% CI) by the CYP17 genotype 335 Genotype A1/A1 A1/A2 A2/A2 Hormone Number (%) 54 (33%) 74 (45%) 36 (22%) P for trend DHEA S (ng/ml) [ 10.6%] b 1,519.3 [+0.06%] NS ( ) a ( ) ( ) Androstenedione (ng/ml) [ 12.9%] 1.31 [ 16.7%] ( ) ( ) ( ) Free testosterone (pg/ml) [ 2.7%] 10.5 [ 9.9%] ( ) ( ) ( ) Testosterone (ng/ml) [+8.1%] 4.76 [ 4.8%] NS ( ) ( ) ( ) Estradiol (pg/ml) [+3.1%] 18.2 [ 8.0%] NS ( ) ( ) ( ) a 95% CI. b Differences (%) compared with A1/A1 genotype. Table 2 Mean hormone level (95% CI) by the SRD5A2 genotype Genotype V/V V/L L/L Hormone Number (%) 52 (32%) 82 (50%) 30 (18%) P for trend DHEA S (ng/ml) [ 9.1%] b [ 5.5%] NS ( ) a ( ) ( ) Androstenedione (ng/ml) [ 7.1%] 1.56 [+1.6%] NS ( ) ( ) ( ) Free testosterone (pg/ml) [ 2.5%] 11.8 [+5.2%] NS ( ) ( ) ( ) Testosterone (ng/ml) [+0.8%] 5.32 [+5.1%] NS ( ) ( ) ( ) Estradiol (pg/ml) [ 14.4%] 20.3 [ 4.7%] NS ( ) ( ) ( ) a 95% CI (confidence interval). b Differences (%) compared with V/V genotype. level were ng/ml (DHEA S, mean7s.e.), ng/ml (androstenedione), pg/ml (fte), pg/ml (Te), and pg/ml (E2), respectively. The genotype-serum steroid hormone analysis revealed a linear decreasing trend across the CYP17 genotypes for fte and androstenedione levels, resulting in 9.9% (fte) and 16.7% (androstenedione) lower levels of each hormone in the A2 homozygote (Table 1). The P- values for the linear decreasing trend across the CYP17 genotype were 0.04 for fte, and 0.02 for androstenedione, respectively. As for the SRD5A2 genotype, no associations were found between genotypes and any hormone fractions (Table 2). In the analysis of the CYP17 SRD5A2 gene interaction, compared with the males homozygous for both the A1 and V allele, those with other genotype combinations did not have significantly increased or decreased mean levels of fte and androstenedione (Tables 3, 4). However, we observed 15% increase of fte across the SRD5A2 genotype among the A1/A1 genotype and 17% increase of androstenedione among the A1/A2 genotype (Tables 3, 4). For androstenedione, the increasing trend was statistically significant (P ¼ 0.047). In other hormone levels (DHEA S, Te, and E2), no significant gene interaction between the genotypes was observed. Discussion Recent molecular studies have suggested that the genetic polymorphisms of CYP17 and SRD5A2, which encode the key enzymes at androgen synthesis and metabolism, might affect sex hormone production and serum levels. Carey et al 17 first reported a positive association between the A2 allele of CYP17 and the risk of hyperandrogenic disease (polycystic ovary syndrome and male pattern baldness). Following this report, two groups revealed that the A2 allele was associated with elevated concentrations of estradiol in premenopausal and postmenopausal women. 18,19 So far, a few studies suggested that the A2 allele might increase the risk of breast cancer, while other studies suggested no such association. 20,21 On the other hand, in prostate cancer, the relation between the CYP17 polymorphism and prostate cancer risk has been conflicting. Although a few groups including ours reported that the A1 allele of CYP17 increased the risk of prostate cancer, other studies reported a negative association or converse results In the present study, the linear decreasing trends across the CYP17 genotypes were observed with significance for fte and androstenedione, a precursor of testosterone. The mean levels of fte and androstenedione in A2 homozygous males were 9.9 and 16.7% lower when
4 336 Table 3 Mean free testosterone level by the CYP17 and SRD5A2 genotype SRD5A2 genotype CYP17 genotype V/V V/L L/L P trend for the SRD5A2 genotype A1/A (18) 11.2 (27) 13.3 (9) NS A1/A (24) 11.0 (36) 12.0 (14) NS A2/A (10) 10.7 (19) 9.7 (7) NS P trend for the CYP17 genotype NS NS 0.02 P interaction, NS () ¼ number. Table 4 Mean androstenedione level by the CYP17 and SRD5A2 genotype SRD5A2 genotype CYP17 genotype V/V V/L L/L P trend for the SRD5A2 genotype A1/A (18) 1.47 (27) 1.47 (9) NS A1/A (24) 1.46 (36) 1.72 (14) A2/A (10) 1.30 (19) 1.34 (7) NS P trend for the CYP17 genotype NS NS P interaction, NS () ¼ number. compared with A1 homozygous males, while total testosterone and DHEA S did not appear to be related. In contrast, Haiman et al 10 and Allen et al 22 recently failed to find a significant relation between the CYP17 genotype and circulating steroid hormone levels regardless of their larger sample sizes, entering 377 control males and 622 control males. There might be a possibility that the influence of the CYP17 genotypes on enzyme activity could be more prominent in Asians than in Caucasians. Allen et al 22 used a cohort derived from a Caucasian population, while Haiman et al 10 did not mention the ethnicity of their cohort. In addition, the mean age of the cohort in Allen s study was nearly 20 y younger than the current study (47 y vs 66 y). 22 Thus, further investigation of the cohort, which should be well stratified by both ethnicity and age, may be needed to support that hypothesis. Although the role of estrogen for prostate cancer development has not been well understood, CYP17 is also accountable for regulation of estrogen and some studies showed that estrogen may support androgen s effect on prostate growth. 23 The present result showed no significant difference between E2 level and the polymorphism of CYP17. So far, a few findings supported the hypothesis that the polymorphism of CYP17 may have an effect on estrogen biosynthesis in female subjects, while in male subjects the relation was tenuous and limited. 10,18,19 The difference in the metabolic pathway by gender may partly explain this discrepancy. The present finding that the CYP17 A1 allele was related to lower free testosterone level corroborated the results for our previous observation in a Japanese case-controlled study in which the A1 allele was associated with an increased risk of prostate cancer with a gene dosage effect. 11 Although the relation between the serum testosterone levels and prostate cancer may be controversial, the trend of increasing prostate cancer development was observed with increasing serum-free ( ¼ bio-available) testosterone level as assessed by the ratio of testosterone to serum hormone binding protein (SHBG). 24 In addition, a single measurement of testosterone was suggested to reliably reflect mean annual androgen concentrations. 25 Thus, it is suggested that males with the CYP17 A1 allele could be exposed to higher levels of androgen throughout their life and end up being amenable to prostate cancer. Epidemiologic findings have also been suggesting ethnicity-specific differences in genotype frequency for SRD5A2. 7,15 The assumption that the L allele of the V89L in the SRD5A2 might be protective to prostate cancer has been gaining favor ,16 In support of this view, we recently reported that the V allele may dominantly increase the risk of prostate cancer (vs L/L genotype; OR, 1.69; 95% CI; ). 16 Studies of analyses between the polymorphism of SRD5A2 (V89L) and 5areductase enzyme activity were originally conducted by Makridakis et al. 15,26 In their study, they showed that males with the L homozygous allele had lower 5areductase activity compared with males with the V homozygous allele, as evidenced by the finding that L homozygous males showed a 38% lower serum level of A-diol-g, which is a direct metabolite of DHT and may be an indication of SRD5A2 activity. They also revealed a significant difference in 5a-reductase enzyme activity between the L allele and V allele in vitro. 26 Recently, Hsing et al 14 and Allen et al 22 reported that males with the V/L and L/L genotypes showed a lower level of A- diol-g, compared with males with the V/V genotypes, among Chinese (24%) and Caucasian populations (2.4%). These findings may suggest that the impact of the SRD5A2 polymorphism on 5a-reductase activity appears more prominent in low-risk populations, but the serum testosterone level in the L/L genotype was 17% higher than V/V genotype in the study of Hsing et al. 14 In the
5 present study, we found neither a single effect of the SRD5A2 polymorphism nor a definite combined influence of the CYP17 and SRD5A2 polymorphisms on circulating hormone levels. Although there might be a small relation between serum androgen levels and the SRD5A2 genotype, the impact of the SRD5A2 polymorphism on serum androgen level would not be as robust as that of the CYP17 polymorphism. Since the 5areductase activity may play a major role in prostate tissue levels, studies of the effect of the SRD5A2 polymorphism on androgen activity in prostate tissue levels are required. Serum hormone levels may be affected by environmental factors such as life style, dietary habit, and fat intake, and it will be challenging to find a difference by genetic polymorphism alone. 27 Asian ethnic populations may be more suitable to evaluate the differences in mean hormone levels across the CYP17 and SRD5A2 genotypes, because the Japanese are less affected by environmental factors for prostate cancer than Caucasians. 28 However, the present study might have a flaw in that no information of these life styles on subjects were obtained. Furthermore, because our study subjects were limited to a relatively small number of normal men aged 60 y or over with normal serum PSA, it remains unknown whether the findings of this study apply to prostate cancer patients. To further delineate the roles of the polymorphisms of the two genes in prostate carcinogenesis, a larger study including both normal and prostate cancer subjects is required and warranted. The present limited findings suggested that the significance of the CYP17 polymorphism in determining levels of some androgens therefore affected the risk of prostate cancer, while the SRD5A2 polymorphism may have little effect on the serum level of testosterone among Japanese populations. A larger study will be needed to examine gene gene interactions in both normal males and prostate cancer patients. References 1 Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, CA Cancer J Clin 1998; 48: Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, CA Cancer J Clin 1999; 49: Ross R et al. Serum testosterone levels in healthy young black and white men 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. J Natl Cancer Inst 1986; 76: Ross RK et al. 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992; 339: de Jong FH et al. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch Japanese case control study. Cancer Res 1991; 51: Shaneyfelt T, Husein R, Bubley G, Mantzoros CS. Hormonal predictors of prostate cancer: a meta-analysis. J Clin Oncol 2000; 18: Lunn RM, Bell DA, Mohler JL, Taylor JA. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenesis 1999; 20: Gsur A et al. A polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer 2000; 87: Wadelius M et al. Prostate cancer associated with CYP17 genotype. Pharmacogenetics 1999; 9: Haiman CA et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: Habuchi T et al. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect. Cancer Res 2000; 60: Febbo PG et al. The V89L polymorphism in the 5 alpha-reductase type 2 gene and risk of prostate cancer. Cancer Res 1999; 59: Nam RK et al. V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology 2001; 57: Hsing AW et al. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2001; 10: Makridakis N et al. A prevalent missense substitution that modulates activity of prostatic steroid 5 alpha-reductase. Cancer Res 1997; 57: Li Z et al. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population. JUrol 2003; 169: Carey AH et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994; 3: Feigelson HS et al. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 1998; 58: Haiman CA et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999; 59: Ye Z, Parry JM. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis 2002; 17: Feigelson HS et al. A polymorphism in the CYP17 gene increases the risk of breast cancer. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Cancer Res 1997; 57: Allen NE, Forrest MS, Key TJ. The association between polymorphisms in the CYP17 and 5 alpha-reductase (SRD5A2) genes and serum androgen concentrations in men. Cancer Epidemiol Biomarkers Prev 2001; 10: Walsh PC, Wilson JD. The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest 1976; 57: Gann PH et al. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996; 88: Vermeulen A, Verdonck G. Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. J Clin Endocrinol Metab 1992; 74: Makridakis NM, di Salle E, Reichardt JK. Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II. Pharmacogenetics 2000; 10: Ross RK, Henderson BE. Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 1994; 86: Oishi K, Yoshida O, Schroeder FH. The geography of prostate cancer and its treatment in Japan. Cancer Surv 1995; 23:
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis Maarten C. Bosland Carcinoma of the prostate is the most frequently diagnosed malignancy and the second leading cause of death as a result
More informationEvidence for an association between the SRD5A2 (type II steroid 5α-reductase) locus and prostate cancer in Italian patients
147 Evidence for an association between the SRD5A2 (type II steroid 5α-reductase) locus and prostate cancer in Italian patients K. Margiotti a,b, F. Sangiuolo a, A. De Luca a, F. Froio c, C.L. Pearce d,
More informationRelationship between CYP17 gene polymorphisms and risk of prostate cancer
Relationship between CYP17 gene polymorphisms and risk of prostate cancer J. Song, Z.-H. Tao, X.-Y. Liu, S. Gong and L. Gan Centre for Preclinical Medicine, SiChuan Medical University, Luzhou, Sichuan,
More informationCorrelations between the COMT gene rs4680 polymorphism and susceptibility to ovarian cancer
Correlations between the COMT gene rs4680 polymorphism and susceptibility to ovarian cancer W. Pan 1 and H. Liao 2 1 Department of Obstetrics and Gynecology, Huangshi Central Hospital of Hubei Province
More informationCYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women
CYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women L. Yang, X.Y. Wang, Y.T. Li, H.L. Wang, T. Wu, B. Wang, Q. Zhao, D. Jinsihan and L.P. Zhu The Department of Mammary
More informationISSN X (Print) Original Research Article. DOI: /sjams *Corresponding author Dr. V. Ananthan
DOI: 10.21276/sjams.2016.4.7.70 Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2016; 4(7E):2630-2635 Scholars Academic and Scientific Publisher (An International Publisher
More informationCYP17 Gene Polymorphism and its Association in North Indian Prostate Cancer Patients
CYP17 Gene Polymorphism and its Association in North Indian Prostate Cancer Patients RANBIR CHANDER SOBTI 1, LIPSY GUPTA 1, HITENDER THAKUR 1, AMLESH SETH 2, SHARWAN K. SINGH 3 and PUSHPINDER KAUR 1 1
More informationAward Number: W81XWH TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer
AD Award Number: W81XWH-04-1-0579 TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer PRINCIPAL INVESTIGATOR: Yuichiro Tanaka, Ph.D. Rajvir Dahiya, Ph.D. CONTRACTING ORGANIZATION:
More informationTITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer
AD Award Number: W81XWH-04-1-0579 TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer PRINCIPAL INVESTIGATOR: Yuichiro Tanaka, Ph.D. CONTRACTING ORGANIZATION: Northern California
More informationAssociation between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population
Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population R. Zhao and M.F. Ying Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University,
More informationPolymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women
www.bioinformation.net Volume 13(5) Hypothesis Polymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women Maniraja Jesintha
More informationSAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:
Patient: Age: 40 Sex: F MRN: SAMPLE PATIENT Order Number: Completed: Received: Collected: SAMPLE REPORT Progesterone ng/ml 0.34 0.95 21.00 DHEA-S mcg/dl Testosterone ng/ml 48 35 0.10 0.54 0.80 430 Sex
More informationGenetic polymorphism in sex hormone metabolism and prostate cancer risk
Genetic polymorphism in sex hormone metabolism and prostate cancer risk E. Ersekerci 1, M. Sofikerim 2, S. Taheri 3, A. Demirtas 1 and F. Halis 4 1 Department of Urology, Erciyes University Faculty of
More informationHormones and Prostate Cancer: What's Next?
Epidemiologic Reviews Copyright 2001 by the Johns Hopkins University Bloomberg School of Public Health All rights reserved Vol. 23, No. 1 Printed in U.S.A. Hormones and Prostate Cancer: What's Next? Ann
More informationHormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase
Patient Name: Patient DOB: Gender: Physician: Test Hormone Balance - Female Report SAMPLE Grote, Mary Jane Batch Number: B6437 2/16/1954 Accession Number: N52281 F Date Received: 2/3/2015 Any Lab Test
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: DAMD17-01-1-0112 TITLE: Genetic Epidemiology of Prostate Cancer PRINCIPAL INVESTIGATOR: Susan L. Neuhausen, Ph.D. CONTRACTING ORGANIZATION: University of California, Irvine Irvine, California
More informationCONTRACTING ORGANIZATION: University of California, Irvine Irvine CA
AD Award Number: DAMD17-01-1-0112 TITLE: Genetic Epidemiology of Prostate Cancer PRINCIPAL INVESTIGATOR: Susan L. Neuhausen, Ph.D. CONTRACTING ORGANIZATION: University of California, Irvine Irvine CA 92697-7600
More informationTable S1. Primers and PCR protocols for mutation screening of MN1, NF2, KREMEN1 and ZNRF3.
Table S1. Primers and PCR protocols for mutation screening of MN1, NF2, KREMEN1 and ZNRF3. MN1 (Accession No. NM_002430) MN1-1514F 5 -GGCTGTCATGCCCTATTGAT Exon 1 MN1-1882R 5 -CTGGTGGGGATGATGACTTC Exon
More informationAssociations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis
Associations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis D. Zhang 1, Q. Li 2, H.-C. Qu 3, T. Yu 2 and Y.-R. Liu 1 1 College of Basic Medical Science,
More informationLinkage analysis: Prostate Cancer
Linkage analysis: Prostate Cancer Prostate Cancer It is the most frequent cancer (after nonmelanoma skin cancer) In 2005, more than 232.000 new cases were diagnosed in USA and more than 30.000 will die
More informationVitamin D receptor gene polymorphism and serum levels of Fetuin-A, Vitamin D and ipth in the hemodialysis patients
In The Name of GOD Vitamin D receptor gene polymorphism and serum levels of Fetuin-A, Vitamin D and ipth in the hemodialysis patients Authors & Affiliations: 1-jamal hallajzadeh; Maraghe University of
More informationIntracrine Androgens Enhance Decidualization and Modulate Expression of Human
Intracrine Androgens Enhance Decidualization and Modulate Expression of Human Endometrial Receptivity Genes. Authors: Douglas A Gibson 1, Ioannis Simitsidellis 1, Fiona L Cousins 1*, Hilary O.D. Critchley
More informationSupplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our
1 2 Supplemental Data: Detailed Characteristics of Patients with MKRN3 Mutations 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Patient 1 was born after an uneventful pregnancy. She presented
More informationOriginal Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk in a Chinese Han population
Int J Clin Exp Med 2014;7(12):5832-5836 www.ijcem.com /ISSN:1940-5901/IJCEM0002117 Original Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk
More informationHormone. Free Androgen Index. 2-Hydroxyestrone. Reference Range. Hormone. Estrone Ratio. Free Androgen Index
Hormonal Health PATIENT: Sample Report TEST REF: TST-12345 Hormonal Health 0.61 0.30-1.13 ng/ml DHEA-S 91 35-430 mcg/dl tient: SAMPLE TIENT e: x: N: Sex Binding Globulin 80 18-114 nmol/l Testosterone 0.34
More informationUrological Oncology. Sung Woon Park, Chul Sung Kim 1, Gilho Lee 2. DOI: /kju INTRODUCTION
www.kjurology.org DOI:10.4111/kju.2010.51.12.824 Urological Oncology Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride
More informationMolecular Epidemiology of Hormone-Metabolic Loci in Prostate Cancer
Epiderryologic Reviews Copyright 2001 by the Johns Hopkins University Bloomberg School of Public Health All rights reserved Vol. 23, No. 1 Printed in U.S.A. Molecular Epidemiology of Hormone-Metabolic
More informationAssociation between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis
Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis Y. Liu, H.L. Liu, W. Han, S.J. Yu and J. Zhang Department of Cardiology, The General Hospital of the
More informationAssociation between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer
Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer M.G. He, K. Zheng, D. Tan and Z.X. Wang Department of Hepatobiliary Surgery, Nuclear Industry 215 Hospital
More informationCYP17 and CYP2C19 gene polymorphisms in patients with endometriosis
Reproductive BioMedicine Online (2010) 20, 286 290 www.sciencedirect.com www.rbmonline.com ARTICLE CYP17 and CYP2C19 gene polymorphisms in patients with endometriosis Gurkan Bozdag a, *, Alpaslan Alp b,
More informationAssociation between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk
Association between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk B.B. Sun, J.Z. Wu, Y.G. Li and L.J. Ma Department of Respiratory Medicine, People s Hospital Affiliated to
More informationSerum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case control study
Cancer Causes Control (2011) 22:1121 1131 DOI 10.1007/s10552-011-9787-7 ORIGINAL PAPER Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case control study
More informationChapter 4 INSIG2 Polymorphism and BMI in Indian Population
Chapter 4 INSIG2 Polymorphism and BMI in Indian Population 4.1 INTRODUCTION Diseases like cardiovascular disorders (CVD) are emerging as major causes of death in India (Ghaffar A et. al., 2004). Various
More informationSolitary and multiple uterine leiomyomas among Caucasian women: two different disorders?
Solitary and multiple uterine leiomyomas among Caucasian women: two different disorders? Maja Pakiz, M.D., M.Sc., a Uros Potocnik, Ph.D., b,c and Igor But, M.D., Ph.D. a,d a Department of General Gynecology
More informationJoint AEPCOS/Endocrine Society Update Meeting in ENDO 2017
Joint AEPCOS/Endocrine Society Update Meeting in Orlando @ ENDO 2017 GUT, MICROBIOME AND FAT: ORIGINS OF PCOS METABOLIC DISEASE? ORANGE COUNTY CONVENTION CENTER, ORLANDO, FL, USA, MARCH 31, 2017 CALL FOR
More informationComprehensivePLUS Hormone Profile with hgh
OLEBound400: 801 SW 16th St Suite 126 Renton WA 98057 425.271.8689 425.271.8674 (Fax) ComprehensivePLUS Hormone Profile with hgh Doctor ID Patient Name 6206 Doe, Jane Age Sex Date of Birth 44 F Date Collected
More informationLack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims
Kobe J. Med. Sci., Vol. 53, No. 4, pp. 151-155, 2007 Lack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims KAORU SAKURAI 1, NAOKI NISHIGUCHI 2, OSAMU SHIRAKAWA 2,
More informationHRAS1 Rare Minisatellite Alleles and Breast Cancer in Australian Women Under Age Forty Years
HRAS1 Rare Minisatellite Alleles and Breast Cancer in Australian Women Under Age Forty Years Frank A. Firgaira, Ram Seshadri, Christopher R. E. McEvoy, Gillian S. Dite, Graham G. Giles, Margaret R. E.
More informationDetection of Cytochrome P450 Polymorphisms in Breast Cancer Patients May Impact on Tamoxifen Therapy
DOI:10.22034/APJCP.2018.19.2.343 Polymorphisms in Drug Metabolizing Genes RESEARCH ARTICLE Editorial Process: Submission:01/03/2017 Acceptance:10/27/2017 Detection of Cytochrome P450 Polymorphisms in Breast
More informationDRIED URINE -INTEGRATIVE MEDICINE
P: 1300 688 522 E: info@nutripath.com.au A: PO Box 442 Ashburton VIC 3142 TEST PATIENT Sex : D Collected : 00-00-0000 111 ROAD TEST SUBURB AB : 00000000 UR#:0000000 TEST PHYSICIAN DR JOHN DOE 111 CLINIC
More informationIL10 rs polymorphism is associated with liver cirrhosis and chronic hepatitis B
IL10 rs1800896 polymorphism is associated with liver cirrhosis and chronic hepatitis B L.N. Cao 1, S.L. Cheng 2 and W. Liu 3 1 Kidney Disease Department of Internal Medicine, Xianyang Central Hospital,
More informationAssociation between the 8q24 rs T/G polymorphism and prostate cancer risk: a meta-analysis
Association between the 8q24 rs6983267 T/G polymorphism and prostate cancer risk: a meta-analysis H.S. Zhu 1 *, J.F. Zhang 1 *, J.D. Zhou 2, M.J. Zhang 1 and H.X. Hu 1 1 Clinical Laboratory, East Suzhou
More informationBIOSYNTHESIS OF STEROID HORMONES
BIOSYNTHESIS OF STEROID HORMONES Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI sw/steroidrepro/inter/08 1 STEROID HORMONES Progestins (21 C) Glucocorticoids (21 C) Mineralocorticoids
More informationSupplementary Figure 1. Principal components analysis of European ancestry in the African American, Native Hawaiian and Latino populations.
Supplementary Figure. Principal components analysis of European ancestry in the African American, Native Hawaiian and Latino populations. a Eigenvector 2.5..5.5. African Americans European Americans e
More informationTransformation of Breast Cancer in Taiwan
Transformation of Breast Cancer in Taiwan Chiun-Sheng Huang, MD, PhD, MPH President, the Breast Cancer Society of Taiwan Professor of Surgery National Taiwan University Hospital More young breast cancers
More informationLack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population
Lack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population J. Zhu 1 *, F. He 2 *, D.D. Zhang 2 *, J.Y. Yang 2, J. Cheng 1, R. Wu 1, B. Gong 2, X.Q. Liu
More informationPositive association of CYP11B2 gene polymorphism with genetic predisposition
(2002) 16, 789 793 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Positive association of CYP11B2 gene polymorphism with genetic predisposition
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview
INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple 1 Insulin Resistance: What is
More informationInvestigating the role of polymorphisms in mir-146a, -149, and -196a2 in the development of gastric cancer
Investigating the role of polymorphisms in mir-146a, -149, and -196a2 in the development of gastric cancer Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong
More informationMyoglobin A79G polymorphism association with exercise-induced skeletal muscle damage
Myoglobin A79G polymorphism association with exercise-induced skeletal muscle damage T. Cui and M.S. Jiang College of Physical Education, Shandong University of Finance and Economics, Ji nan, Shandong,
More informationHirsutism: Diagnosis and Treatment. Roger A. Lobo M.D. Columbia University
Hirsutism: Diagnosis and Treatment Roger A. Lobo M.D. Columbia University Signs of hyperandrogenism Acne, Hirsutism, Alopecia All explained by increased androgen production and/or increased sensitivity
More informationInfluence of interleukin-18 gene polymorphisms on acute pancreatitis susceptibility in a Chinese population
Influence of interleukin-18 gene polymorphisms on acute pancreatitis susceptibility in a Chinese population H.B. Gui 1, X.G. Du 2, Z.H. Fu 3 and X.M. Chen 1 1 Department of Emergency, The First Affiliated
More informationProspective study of MTHFR genetic polymorphisms as a possible etiology of male infertility
Prospective study of MTHFR genetic polymorphisms as a possible etiology of male infertility S.-S. Li 1, J. Li 1, Z. Xiao 2, A.-G. Ren 3 and L. Jin 3 1 Beijing Obstetrics and Gynecology Hospital, Capital
More informationWhen testes make no testosterone: Identifying a rare cause of 46, XY female phenotype in adulthood
When testes make no testosterone: Identifying a rare cause of 46, XY female phenotype in adulthood Gardner DG, Shoback D. Greenspan's Basic & Clinical Endocrinology, 10e; 2017 Sira Korpaisarn, MD Endocrinology
More informationRESEARCH ARTICLE. Lack of Association between the COMT rs4680 Polymorphism and Ovarian Cancer Risk: Evidence from a Meta-analysis of 3,940 Individuals
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.18.7941 RESEARCH ARTICLE Lack of Association between the COMT rs4680 Polymorphism and Ovarian Cancer Risk: Evidence from a Meta-analysis of 3,940 Individuals
More informationAndrogens and prostate cancer: insights from abiraterone acetate and other novel agents
Androgens and prostate cancer: insights from abiraterone acetate and other novel agents Ian Davis Ludwig Institute for Cancer Research Austin Health, Melbourne, Australia Supported in part by an Australian
More informationGEN GEN: THE GENOMIC GENETIC ANALYSIS OF ANDROGEN-METABOLIC GENES AND PROSTATE CANCER AS A PARADIGM FOR THE DISSECTION OF COMPLEX PHENOTYPES
[Frontiers in Bioscience, 4, d596-600, July 15, 1999] GEN GEN: THE GENOMIC GENETIC ANALYSIS OF ANDROGEN-METABOLIC GENES AND PROSTATE CANCER AS A PARADIGM FOR THE DISSECTION OF COMPLEX PHENOTYPES Juergen
More informationPROSTATE CANCER SCREENING: AN UPDATE
PROSTATE CANCER SCREENING: AN UPDATE William G. Nelson, M.D., Ph.D. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins American Association for Cancer Research William G. Nelson, M.D., Ph.D. Disclosures
More informationSALSA MLPA KIT P050-B2 CAH
SALSA MLPA KIT P050-B2 CAH Lot 0510, 0909, 0408: Compared to lot 0107, extra control fragments have been added at 88, 96, 100 and 105 nt. The 274 nt probe gives a higher signal in lot 0510 compared to
More informationDiversity and Frequencies of HLA Class I and Class II Genes of an East African Population
Open Journal of Genetics, 2014, 4, 99-124 Published Online April 2014 in SciRes. http://www.scirp.org/journal/ojgen http://dx.doi.org/10.4236/ojgen.2014.42013 Diversity and Frequencies of HLA Class I and
More informationOriginal Policy Date
MP 2.04.38 Genetic Testing for Helicobacter pylori Treatment Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return
More informationRelationship between SPOP mutation and breast cancer in Chinese population
Relationship between SPOP mutation and breast cancer in Chinese population M.A. Khan 1 *, L. Zhu 1 *, M. Tania 1, X.L. Xiao 2 and J.J. Fu 1 1 Key Laboratory of Epigenetics and Oncology, The Research Center
More informationEuropean Journal of Medical Research. Open Access RESEARCH. Weiming Hao 1,2, Xia Xu 3, Haifeng Shi 1, Chiyu Zhang 2 and Xiaoxiang Chen 4*
https://doi.org/10.1186/s40001-018-0345-6 European Journal of Medical Research RESEARCH Open Access No association of TP53 codon 72 and intron 3 16 bp duplication polymorphisms with breast cancer risk
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationAldehyde Dehydrogenase-2 Genotype Detection in Fingernails among Non-alcoholic Northeastern Thai Population and Derived Gene Frequency
ScienceAsia 28 (2002) : 99-103 Aldehyde Dehydrogenase-2 Genotype Detection in Fingernails among Non-alcoholic Northeastern Thai Population and Derived Gene Frequency Paiboon Mongconthawornchai a, *, Somsong
More informationASSOCIATION BETWEEN MTHFR (C677T) GENE POLYMORPHISM WITH BREAST CANCER IN NORTHERN IRAN
WCRJ 2017; 4 (2): e876 ASSOCIATION BETWEEN MTHFR (C677T) GENE POLYMORPHISM WITH BREAST CANCER IN NORTHERN IRAN A. HEDAYATIZADEH-OMRAN, R. ALIZADEH-NAVAEI, F. TOGHANI-HULARI, O. AMJADI Gastrointestinal
More informationNew: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix.
SALSA MLPA KIT P045-B2 BRCA2/CHEK2 Lot 0410, 0609. As compared to version B1, four reference probes have been replaced and extra control fragments at 100 and 105 nt (X/Y specific) have been included. New:
More informationAssociation of CYP1B1 Polymorphisms with Breast Cancer: A Case-Control Study in the Han Population in Ningxia Hui Autonomous Region, P. R.
Biomarker Insights O r i g i n a l R e s e a r c h Open Access Full open access to this and thousands of other papers at http://www.la-press.com. Association of CYP1B1 Polymorphisms with Breast Cancer:
More informationHLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma
HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma Arezou Sayad 1, Mohammad Taghi Akbari 2**, Mahshid Mehdizadeh 3,4, Mohammad Taheri 1, Abbas Hajifathali 3* 1 Department of Medical
More informationDepartment, Onassis Cardiac Surgery Centre, Athens, Greece
Original Research Hellenic J Cardiol 2014; 55: 126-131 Genetic Variant in the CYP17 Gene and Risk of Premature Coronary Artery Disease Konstantinos Agiannitopoulos 1, Anna Kyparissi 1, Athanasios Manginas
More informationMassoud Houshmand National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
QUID 2017, pp. 669-673, Special Issue N 1- ISSN: 1692-343X, Medellín-Colombia NON-GENE REGION AND INFLUENCES TUMOR CHARACTERISTICS BY LOW-RISK ALLELES IN BREAST CANCER (Recibido el 21-06-2017. Aprobado
More informationCase. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?
Hirsutism Case 24 year old female presented to your office complaining of excess hair growth on her face and abdomen Questions? Started around puberty with gradual progression Irregular menstrual cycle
More informationHuman leukocyte antigen-b27 alleles in Xinjiang Uygur patients with ankylosing spondylitis
Human leukocyte antigen-b27 alleles in Xinjiang Uygur patients with ankylosing spondylitis H.-Y. Zou, W.-Z. Yu, Z. Wang, J. He and M. Jiao Institute of Clinical Medicine, Urumqi General Hospital, Lanzhou
More informationMRC-Holland MLPA. Description version 18; 09 September 2015
SALSA MLPA probemix P090-A4 BRCA2 Lot A4-0715, A4-0714, A4-0314, A4-0813, A4-0712: Compared to lot A3-0710, the 88 and 96 nt control fragments have been replaced (QDX2). This product is identical to the
More informationReproductive. Estrone sulfate Analyte Information
Reproductive Estrone sulfate Analyte Information - 1 - Estrone sulfate Introduction Estrone sulfate (E1-S) is a sulfate derivative of estrone, and is the most abundant form of circulating estrogens in
More informationReproductive DHEA Analyte Information
Reproductive DHEA Analyte Information - 1 - DHEA Introduction DHEA (dehydroepiandrosterone), together with other important steroid hormones such as testosterone, DHT (dihydrotestosterone) and androstenedione,
More informationConditions. Name : dummy Age/sex : xx Y /x. Lab No : xxxxxxxxx. Rep Centre : xxxxxxxxxxx Ref by : Dr. xxxxxxxxxx
Name : dummy Age/sex : xx Y /x Lab No : xxxxxxxxx Rep Centre : xxxxxxxxxxx Ref by : Dr. xxxxxxxxxx Rec. Date : xx/xx/xx Rep Date : xx/xx/xx GENETIC MAPPING FOR ONCOLOGY Conditions Melanoma Prostate Cancer
More informationCYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study
CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study Y.L. Song 1,2, L. Wang 2, J.C. Ren 1 and Z.H. Xu 1 1 Department of Urology, Qilu Hospital, Shandong University, Jinan,
More informationAssociation between MTHFR 677C/T and 1298A/C gene polymorphisms and breast cancer risk
Association between MTHFR 677C/T and 1298A/C gene polymorphisms and breast cancer risk X.F. Zhang 1, T. Liu 2, Y. Li 1 and S. Li 2 1 Department of Breast, Liao Ning Cancer Hospital and Institute, Shenyang,
More informationAssociation between the CYP1A1 polymorphisms and hepatocellular carcinoma: a meta-analysis
Association between the CYP1A1 polymorphisms and hepatocellular carcinoma: a meta-analysis B.W. Yu 1 *, L.Q. Zhang 1 *, X.L. Teng 1, Y. Zhang 1, L.B. Zou 2 and H.Y. Ying 3 l Department of Clinical Laboratory,
More information1. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45
1 2 3 1. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women
More informationLack of association between IL-6-174G>C polymorphism and lung cancer: a metaanalysis
Lack of association between IL-6-174G>C polymorphism and lung cancer: a metaanalysis Y. Liu, X.L. Song, G.L. Zhang, A.M. Peng, P.F. Fu, P. Li, M. Tan, X. Li, M. Li and C.H. Wang Department of Respiratory
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Human Ovarian Steroidogenesis and Gonadotrophin Stimulation Johan
More informationGenetics and Genomics: Influence on Individualization of Medication Regimes
Genetics and Genomics: Influence on Individualization of Medication Regimes Joseph S Bertino Jr., Pharm.D., FCCP Schenectady, NY USA Goals and Objectives To discuss pharmacogenetics and pharmacogenomics
More informationUrinary Hormone Metabolites Estrogen Elite
Test Name Result Range Urinary Estrogens Estradiol 3.71 H 0.78-1.79 µg/g Cr Premeno-luteal or ERT Estrone 10.95 H 2.27-5.22 µg/g Cr Premeno-luteal or ERT Estriol 3.19 H 0.78-1.98 µg/g Cr Premeno-luteal
More informationGynecology-endocrinology
Gynecology-endocrinology FERTILITY AND STERILITY Copyright (fj 1991 The American Fertility Society Vol. 55, No, 5, May 1991 Printed on acid-free paper in U.S.A. Serum androsterone conjugates differentiate
More informationLab Tests Made Simple
Body Fluids Commonly Used for Testing Steroid Hormones Blood Serum (venipuncture) Plasma (venipuncture) Capillary Blood (finger/heel stick) Urine Saliva Limitations of Hormone Testing in Different Body
More informationSALSA MLPA probemix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four probes have been adjusted.
mix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four s have been adjusted. The sex-determining region on chromosome Y (SRY) is the most important
More informationInfluence of the c.1517g>c genetic variant in the XRCC1 gene on pancreatic cancer susceptibility in a Chinese population
Influence of the c.1517g>c genetic variant in the XRCC1 gene on pancreatic cancer susceptibility in a Chinese population Z.M. Zhao*, C.G. Li*, M.G. Hu, Y.X. Gao and R. Liu Department of Surgical Oncology,
More informationUniversity of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke
University of Groningen Metabolic risk in people with psychotic disorders Bruins, Jojanneke IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
More informationInvestigation on the role of XPG gene polymorphisms in breast cancer risk in a Chinese population
Investigation on the role of XPG gene polymorphisms in breast cancer risk in a Chinese population S.H. Ma 1,2, F.H. Ling 2, Y.X. Sun 3, S.F. Chen 2 and Z. Li 1 1 Department of General Surgery, Zhujiang
More informationPREVALENCE OF PROSTATE CANCER AMONG HYPOGONADAL MEN WITH PROSTATE-SPECIFIC ANTIGEN LEVELS OF 4.0 ng/ml OR LESS
ADULT UROLOGY PREVALENCE OF PROSTATE CANCER AMONG HYPOGONADAL MEN WITH PROSTATE-SPECIFIC ANTIGEN LEVELS OF 4.0 ng/ml OR LESS ABRAHAM MORGENTALER AND ERNANI LUIS RHODEN ABSTRACT Objectives. To determine
More informationEstrogen receptor dinucleotide repeat and cytochrome P450c17 gene polymorphisms are associated with susceptibility to endometriosis
ENDOMETRIOSIS Estrogen receptor dinucleotide repeat and cytochrome P450c17 gene polymorphisms are associated with susceptibility to endometriosis Yao-Yuan Hsieh, M.D., a,d Chi-Chen Chang, M.D., a Fuu-Jen
More informationSynthesis of sex steroids
Synthesis of sex steroids CH 3 NAD(P)H NAD(P)+ Dehidroepiandroszteron Androszténdion 17- -hidroxiszteroid dehidrogenáz CH 3 dehydroepiandrosterone Dehidroepiandroszteron (DHEA) 3SDH Koleszterin CH 3 aromatase
More informationThe study of effects common paraoxonase polymorphism (L55M) on atherosclerosis risk in diabetic patients by PCR-RFLP
Available online at www.pelagiaresearchlibrary.com European Journal of Experimental Biology, 203, 3(3):52-56 ISSN: 2248 925 CODEN (USA): EJEBAU The study of effects common paraoxonase polymorphism (L55M)
More informationRelationship between bone resorption and adrenal sex steroids and their derivatives in oophorectomized women
FERTILITY AND STERILITY VOL. 82, NO. 6, DECEMBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Relationship between bone
More informationCytochrome P450 2E1 RsaI/PstI and DraI Polymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han Population in Inner Mongolia
www.springerlink.com Chin J Cancer Res 23(2): 107-111, 2011 107 Original Article Cytochrome 450 2E1 RsaI/stI and DraI olymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han opulation in Inner
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationProlactin modulates peripheral androgen metabolism*
FERTILITY AND STERILITY Copyright 1986 The American Fertility Society Printed in USA, Prolactin modulates peripheral androgen metabolism* Paulo Serafini, M,D, t Rogerio A, Lobo, M,D,:j: Department of Obstetrics
More informationCONTRACTING ORGANIZATION: University of Minnesota St Paul, MN 55108
AD Award Number: W81XWH-06-1-0778 TITLE: Dietary Fat, Eicosanoids and Breast Cancer Risk PRINCIPAL INVESTIGATOR: Lindsay Orr CONTRACTING ORGANIZATION: University of Minnesota St Paul, MN 55108 REPORT DATE:
More information